Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Market Covaris' DNA Shearing Tech for Use with SureSelect

Premium

Agilent Technologies and Covaris said this week that they have signed a co-marketing agreement.

Under the agreement, Agilent will market Covaris' S2 DNA shearing system for use with its SureSelect Target Enrichment System, a solution-based DNA selection method for high-throughput sequencing.

Covaris has also developed a SureSelect accessory kit to help Agilent customers integrate its shearing method, which is based on the company's adaptive focused acoustic technology, into their workflows.

Agilent said it will continue to work with Covaris to develop new SureSelect protocols and products.

"So far, SureSelect customers have found our protocols to be very easy to follow and extremely robust, so I believe we've made a good choice to recommend the use of the Covaris S2," said Fred Ernani, Agilent's senior product manager for emerging genomic applications, in a statement.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.